Award
Delivery Order #SPE2DR26F5G5B
Delivery Order for Ondansetron HCL Vials Awarded to AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$21.70
Ceiling
$21.70
Awarded
February 23, 2026
Period of Performance
Feb 23, 2026 – Feb 24, 2026
Identifier
SPE2DR26F5G5B
NAICS
424210
This award represents a delivery order contract granted to AmerisourceBergen Drug Corporation, a prominent healthcare solutions and pharmaceutical distribution company. The contract concerns the supply of Ondansetron HCL 4 mg/2 ml vials, a medication used to prevent nausea and vomiting in patients undergoing chemotherapy and surgery. It is part of a larger, ongoing Indefinite Delivery Vehicle (IDV) contract previously awarded to AmerisourceBergen, emphasizing their key role in the pharmaceutical supply chain for public health agencies. The contract focuses on the timely delivery of these pharmaceutical products to support healthcare facilities. This order was issued competitively under the umbrella of the existing IDV, ensuring compliance with federal procurement regulations. The performance period for this delivery order is a short-term, specific timeframe, demonstrating a precise and targeted fulfillment schedule. The contract further underlines AmerisourceBergen's importance in facilitating critical medication distribution to improve patient care outcomes.
Description
4570926041!ONDANSETRON HCL 4 MG/2 ML VIAL 2ML